Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. 1986

A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush

Selective in vitro photodestruction of HPB-ALL human T-cell leukemia cells was accomplished using the photosensitizer chlorin e6 coupled through dextran molecules to an anti-T-cell monoclonal antibody (mAb), anti-Leu-1. Conjugates with mAb/chlorin molar ratios as high as 1:36 retained mAb binding activity, and the absorption spectrum and quantum efficiency for singlet oxygen production of bound chlorin (0.7 +/- 0.2) were unchanged from that of the free photosensitizer. Phototoxicity, as measured by a clonogenic assay and by uptake of ethidium bromide, was dependent on the doses of both mAb-chlorin and 630- to 670-nm light, was enhanced by 2H2O, and was observed only in target populations that bound the mAb. Similarly, free chlorin e6 in solution had no photodynamic effect in amounts 100 times more than that carried by the mAb. For this antibody-targeted system, approximately 10(10) molecules of singlet oxygen were necessary to kill a cell.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004996 Ethidium A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide. Ethidium Bromide,Homidium Bromide,Novidium,Bromide, Ethidium,Bromide, Homidium
D006800 Deltaretrovirus Infections Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED). BLV Infections,HTLV Infections,HTLV-BLV Infections,BLV Infection,Deltaretrovirus Infection,HTLV BLV Infections,HTLV Infection,HTLV-BLV Infection,Infection, Deltaretrovirus,Infections, Deltaretrovirus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 1991, Annals of the New York Academy of Sciences,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 2000, British journal of cancer,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 1992, Biotechnology progress,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
June 1990, Proceedings of the National Academy of Sciences of the United States of America,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 1989, Biofizika,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
April 2011, Lasers in surgery and medicine,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 1989, Progress in clinical and biological research,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
December 1998, International journal of oncology,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
January 2024, European journal of medicinal chemistry,
A R Oseroff, and D Ohuoha, and T Hasan, and J C Bommer, and M L Yarmush
November 1985, Cancer research,
Copied contents to your clipboard!